Because each patient's
circumstances vary,
we offer a range of programs tailored to help patients in the way they need it most after the prescribing decision has been made.
For U.S. Healthcare Professionals
Because each patient's
For adult patients with moderately to severely active UC or CD when other therapies have not worked well enough or cannot be tolerated.
Affordability
EntyvioConnect understands that each patient’s financial circumstances are unique, which is why EntyvioConnect works closely with eligible patients to help them afford their treatment.
Does your patient need support with co‑pay costs?
- Co‑Pay Program: Eligible commercially insured patients pay as little as $5 per dose,* up to a total benefit of $20,000 per year
- For patients who are government‑insured, underinsured, or rendered uninsured: Patient Support Managers can provide information about financial assistance options
- Patient Assistance Program (PAP): Download and complete the PAP form for patients who may need additional financial assistance
Download resources for treatment affordability
You can speak directly to
a Patient Support Manager for
more information at 1‑855‑ENTYVIO
(1‑855‑368‑9846),
Monday to Friday, from 8 am to 8 pm ET (except holidays).
*The EntyvioConnect Co-Pay Program ("Co-Pay Program") provides financial support for commercially insured patients who qualify for the Co-Pay Program. The Co-Pay Program cannot be used if patient is a beneficiary of, or any part of the prescription is covered by: 1) any federal-, state-, or government-funded healthcare program (Medicare, Medicare Advantage, Medicaid, TRICARE, etc.), including a state pharmaceutical assistance program (the Federal Employees Health Benefit [FEHB] Program is not a government-funded healthcare program for the purpose of this offer), 2) the Medicare Prescription Drug Program (Part D), or if patient is currently in the coverage gap, or 3) insurance that is paying the entire cost of the prescription. Patient may not seek reimbursement from any other plan or program (Flexible Spending Account [FSA], Health Savings Account [HSA], Health Reimbursement Account [HRA], etc.) for any out-of-pocket costs covered by the Co-Pay Program. Patient or healthcare provider may be required to submit an Explanation of Benefits (EOB) following each infusion to the Co-Pay Program. Takeda reserves the right to change or end the Co-Pay Program at any time without notice, and other terms and conditions may apply. Offer not valid for patients under 18 years of age. Assistance under the Co-Pay Program is not transferable. The Co-Pay Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use is prohibited by your insurance provider. If your insurance situation changes you must notify EntyvioConnect at 1-844-368-9846. This offer is not transferable and is limited to one offer per person and may not be combined with any other coupon, discount, prescription savings card, rebate, free trial, patient assistance, or other offer. Not valid if reproduced.
EntyvioConnect At a Glance
EntyvioConnect offers your patients support throughout the entire insurance approval process.
